Gland Pharma shareholding pattern
GLAND
1650
37.80 (-2.24%)Last updated on 24 Dec, 2025 | 15:48 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Gland Pharma FAQs
As of 12-2025, the promoter shareholding in Gland Pharma stands at 51.83% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Gland Pharma is 7.9% and 1.17% respectively.
The retail shareholding of the Gland Pharma is 7.63%.
Changes in shareholding patterns of Gland Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Gland Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
